Advertisement

Topics

Neurocrine Announces Long-Term Results Evaluating INGREZZA® for the Treatment of Adults with ...

13:34 EST 14 Nov 2017 | BioMedReports - Blog

"We are pleased with the long-term data, which demonstrate the ability of INGREZZA to effectively improve the symptoms of tardive dyskinesia with durable response," said

Read more...

Original Article: Neurocrine Announces Long-Term Results Evaluating INGREZZA® for the Treatment of Adults with ...

NEXT ARTICLE

More From BioPortfolio on "Neurocrine Announces Long-Term Results Evaluating INGREZZA® for the Treatment of Adults with ..."

Advertisement
Quick Search
Advertisement
Advertisement